Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation

Archives of Oral Biology

Volumn 44, Issue 1, 1999, Pages 55-66

  Kawashima, N ^b   Stashenko, P ^a  

^a FORSYTH INSTITUTE   (United States)

^b NONE

Author keywords

Bone resorption; Cytokines; Inflammation; Periapical

Indexed keywords

AUTACOID; CYTOKINE; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HELPER CELL; INFLAMMATORY DISEASE; LYMPHOCYTIC INFILTRATION; MALE; METABOLISM; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOLYSIS; POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REGRESSION ANALYSIS; SOUTHERN BLOTTING; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TOOTH PERIAPICAL DISEASE;

EID: 0032936453     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(98)00094-6     Document Type: Article

References (64)

1. al-Humidan A., Ralston S.H., Hughes D.E., Chapman K., Aarden L., Russell R.G., Gowen M. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. Journal of Bone and Mineral Research. 6:1991;3-8.
2. Arenzana-Seisdedos F., Virelizier J.L., Fiers W. Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. Journal of Immunology. 134:1985;2444-2448.
3. Bando Y., Henderson B., Meghji S., Poole S., Harris M. Immunocytochemical localization of inflammatory cytokines and vascular adhesion receptors in radicular cysts. Journal of Oral Pathology and Medicine. 22:1993;221-227.
4. 2+ in murine osteoclasts. Journal of Biological Chemistry. 269:1994;13817-13824.
5. Collart M.A., Belin D., Vassalli J.D., de Kossodo S., Vassalli P. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. Journal of Experimental Medicine. 164:1986;2113-2118.
6. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB Journal. 8:1994;1314-1325.
7. Dinarello C.A., Ikejima T., Warner S.J., Orencole S.F., Lonnemann G., Cannon J.G., Libby P. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. Journal of Immunology. 139:1987;1902-1910.
8. Elias J.A., Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. Journal of Immunology. 145:1990;161-166.
9. Elias J.A., Tang W., Horowitz M.C. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology. 136:1995;489-498.
10. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. Journal of Experimental Medicine. 170:1989;2081-2095.
11. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology. 147:1991;3815-3822.
12. Formigli L., Orlandini S.Z., Tonelli P., Giannelli M., Martini M., Brandi M.L., Bergamini M., Orlandini G.E. Osteolytic processes in human radicular cysts: morphological and biochemical results. Journal of Oral Pathology and Medicine. 24:1995;216-220.
13. Gerrard T.L., Siegel J.P., Dyer D.R., Zoon C. Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes. Journal of Immunology. 138:1987;2535-2540.
14. Girasole G., Jilka R.L., Passeri G., Boswell S., Boder G., Williams D.C., Manolagas S.C. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. Journal of Clinical Investigation. 89:1992;883-891.
15. Gowen M., Mundy G.R. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. Journal of Immunology. 136:1986;2478-2482.
16. Gowen M., Nedwin G.E., Mundy G.R. Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. Journal of Bone and Mineral Research. 1:1986;469-474.
17. Gowen M., Chapman K., Littlewood A., Hughes D., Evans D., Russell G. Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology. 126:1990;1250-1255.
18. Horowitz, M.C., Lorenzo, J.A., 1996. Local regulators of bone: IL-1, TNF, lymphotoxin, interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 family, and additional cytokines. Principles of Bone. Academic Press, San Diego, pp. 687-700.
19. Horsmanheimo L., Harvima I.T., Jarvikallio A., Harvima R.J., Naukkarinen A., Horsmanheimo M. Mast cells are one major source of interleukin-4 in atopic dermatitis. British Journal of Dermatology. 131:1994;53-348.
20. Hsu S.M., Zhao X. Localization of interleukin-1 in normal or reactive lymphoid tissues and skin: abundance of IL-1 in interdigitating reticulum cells. Lymphokine Research. 6:1987;13-18.
21. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T. IL-6 is produced by osteoblasts and induces bone resorption. Journal of Immunology. 145:1990;3297-3303.
22. Kasono K., Sato K., Sato Y., Tsushima T., Shizume K., Demura H. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. Bone and Mineral. 21:1993;179-188.
23. Kaushansky K., Broudy V.C., Harlan J.M., Adamson J.W. Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo. Journal of Immunology. 141:1988;3410-3415.
24. Kawashima N., Okiji T., Kosaka T., Suda H. Kinetics of macrophages and lymphoid cells during the development of experimentally induced periapical lesions in rat molars: a quantitative immunohistochemical study. Journal of Endodontics. 22:1996;311-316.
25. Key L.L. Jr, Ries W.L., Rodriguiz R.M., Hatcher H.C. Recombinant human interferon gamma therapy for osteopetrosis. Journal of Pediatrics. 121:1992;119-124.
26. Key L.L. Jr, Rodriguiz R.M., Willi S.M., Wright N.M., Hatcher H.C., Eyre D.R., Cure J.K., Griffin P.P., Ries W.L. Long-term treatment of osteopetrosis with recombinant human interferon gamma. New England Journal of Medicine. 332:1995;1594-1599.
27. Klaushofer K., Horandner H., Hoffmann O., Czerwenka E., Konig U., Koller K., Peterlik M. Interferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria. Journal of Bone and Mineral Research. 4:1989;585-606.
28. Lacey D.L., Erdmann J.M., Teitelbaum S.L., Tan H.L., Ohara J., Shioi A. Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology. 136:1995;2367-2376.
29. Lowik C.W., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O.L., Aarden L.A., Papapoulos S.E. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochemical and Biophysical Research Communications. 162:1989;1546-1552.
30. Mann G.N., Jacobs T.W., Buchinsky F.J., Armstrong E.C., Li M., Ke H.Z., Ma Y.F., Jee W.S., Epstein S. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology. 135:1994;1077-1083.
31. Marie P.J., Hott M., Launay J.M., Graulet A.M., Gueris J. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation. Journal of Clinical Endocrinolology and Metabolism. 77:1993;824-830.
32. Mauviel A., Temime N., Charron D., Loyau G., Pujol J.P. Interleukin-1 alpha and beta induce interleukin-1 beta gene expression in human dermal fibroblasts. Biochemical and Biophysical Research Communications. 156:1988;1209-1214.
33. Meghji S., Qureshi W., Henderson B., Harris M. The role of endotoxin and cytokines in the pathogenesis of odontogenic cysts. Archives of Oral Biology. 41:1996;523-531.
34. Miossec P., Chomarat P., Dechanet J., Moreau J.F., Roux J.P., Delmas P., Banchereau J. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis and Rheumatism. 37:1994;1715-1722.
35. Modrowski D., Godet D., Marie P.J. Involvement of interleukin 1 and tumour necrosis factor alpha as endogenous growth factors in human osteoblastic cells. Cytokine. 7:1995;720-726.
36. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology. 7:1989;145-173.
37. Muchamuel T., Menon S., Pisacane P., Howard M.C., Cockayne D.A. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. Journal of Immunology. 158:1997;2898-2903.
38. Okiji T., Kawashima N., Kosaka T., Kobayashi C., Suda H. Distribution of Ia antigen-expressing nonlymphoid cells in various stages of induced periapical lesions in rat molars. Journal of Endodontics. 20:1994;27-31.
39. Onoe Y., Miyaura C., Kaminakayashiki T., Nagai Y., Noguchi K., Chen Q.R., Seo H., Ohta H., Nozawa S., Kudo I. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. Journal of Immunology. 156:1996;758-764.
40. Owens J.M., Gallagher A.C., Chambers T.J. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. Journal of Immunology. 157:1996;936-940.
41. Prabhu A., Michalowicz B.S., Mathur A. Detection of local and systemic cytokines in adult periodontitis. Journal of Periodontology. 67:1996;515-522.
42. Ralston S.H., Ho L.P., Helfrich M.H., Grabowski P.S., Johnston P.W., Benjamin N. Nitric oxide: a cytokine-induced regulator of bone resorption. Journal of Bone and Mineral Research. 10:1995;1040-1049.
43. Riancho J.A., Zarrabeitia M.T., Mundy G.R., Yoneda T., Gonzalez-Macias J. Effects of interleukin-4 on the formation of macrophages and osteoclast-like cells. Journal of Bone and Mineral Research. 8:1993;337-1344.
44. Romas E., Udagawa N., Zhou H., Tamura T., Saito M., Taga T., Hilton D.J., Suda T., Ng K.W., Martin T.J. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. Journal of Experimental Medicine. 183:1996;2581-2591.
45. Seitz M., Loetscher P., Dewald B., Towbin H., Baggiolini M. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. European Journal of Immunology. 26:1996;2198-2202.
46. Sieling P.A., Wang X.H., Gately M.K., Oliveros J.L., McHugh T., Barnes P.F., Wolf S.F., Golkar L., Yamamura M., Yogi Y. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. [Published erratum appears in Journal of Immunology 153, 5347.]. Journal of Immunology. 153:1994;3639-3647.
47. Stashenko P., Dewhirst F.E., Peros W.J., Kent R.L., Ago J.M. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. Journal of Immunology. 138:1987;1464-1468.
48. Stashenko P., Jandinski J.J., Fujiyoshi P., Rynar J., Socransky S.S. Tissue levels of bone resorptive cytokines in periodontal disease. Journal of Periodontology. 62:1991;504-509.
49. Stashenko. P., Teles, R., D'Souza, R. Periapical Inflammatory responses and their modulation. Critical Reviews in Oral Biology and Medicine, (in press) 1998.
50. Stashenko P., Wang C.Y., Tani-Ishii N., Yu S.M. Pathogenesis of induced rat periapical lesions. Oral Surgery, Oral Medicine, and Oral Pathology. 78:1994;494-502.
51. Taga T., Hibi M., Hirata Y., Yamasaki K., Yasukawa K., Matsuda T., Hirano T., Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 58:1989;573-581.
52. Takahashi N., Mundy G.R., Roodman G.D. Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. Journal of Immunology. 137:1986;3544-3549.
53. Tani-Ishii N., Wang C.Y., Tanner A., Stashenko P. Changes in root canal microbiota during the development of rat periapical lesions. Oral Microbiology and Immunology. 9:1994;129-135.
54. Tani-Ishii N., Wang C.Y., Stashenko P. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. Oral Microbiology and Immunology. 10:1995;213-219.
55. Tilg H., Trehu E., Atkins M.B., Dinarello C.A., Mier J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 83:1994;113-118.
56. Trepicchio W.L., Bozza M., Pedneault G., Dorner A.J. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. Journal of Immunology. 157:1996;3627-3634.
57. Turner M., Chantry D., Buchan G., Barrett K., Feldmann M. Regulation of expression of human IL-1 alpha and IL-1 beta genes. Journal of Immunology. 143:1989;3556-3561.
58. Vargas S.J., Naprta A., Lee S.K., Kalinowski J., Kawaguchi H., Pilbeam C.C., Raisz L.G., Lorenzo J.A. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy. Journal of Bone and Mineral Research. 11:1996;1926-1934.
59. Wang C.Y., Stashenko P. The role of interleukin-1 alpha in the pathogenesis of periapical bone destruction in a rat model system. Oral Microbiology and Immunology. 8:1993;50-56.
60. Wang C.Y., Tani-Ishii N., Stashenko P. Bone-resorptive cytokine gene expression in periapical lesions in the rat. Oral Microbiology and Immunology. 12:1997;65-71.
61. Windhagen A., Anderson D.E., Carrizosa A., Williams R.E., Hafler D.A. IL-12 induces human T cells secreting IL-10 with IFN-gamma. Journal of Immunology. 157:1996;1127-1131.
62. Yamamoto M., Fujihashi K., Hiroi T., McGhee J.R., Van Dyke T.E., Kiyono H. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. Journal of Periodontal Research. 32:1997;115-119.
63. Yu S.M., Stashenko P. Identification of inflammatory cells in developing rat periapical lesions. Journal of Endodontics. 13:1987;535-540.
64. Zhang X.G., Gu J.J., Lu Z.Y., Yasukawa K., Yancopoulos G.D., Turner K., Shoyab M., Taga T., Kishimoto T., Bataille R. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. Journal of Experimental Medicine. 179:1994;1337-1342.